Home » IPO Articles

Eton Pharmaceutical (ETON) Plans to Raise $0 in October 30th IPO

Eton Pharmaceutical (ETON) is planning to raise $0 in an initial public offering on Tuesday, October 30th, IPO Scoop reports. The company will issue 0 shares at a price of $0.00 per share. The company has a market-cap of $97.9 million. National Securities Corporation acted as the underwriter for the IPO. Eton Pharmaceutical provided the following description of their company for its IPO: ”  Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing... 
 

Niu Technologies Prices IPO at $10.50-$12.50 Per Share (NIU)

Niu Technologies (NIU) is planning to raise $95 million in an IPO on Friday, October 19th, IPO Scoop reports. The company will issue 8,300,000 shares at a price of $10.50-$12.50 per share. In the last 12 months, Niu Technologies generated $151.5 million in revenue and had a net loss of $58.6 million. Niu Technologies has a market cap of $869.8 million. Credit Suisse and Citigroup acted as the underwriters for the IPO and Needham & Company was co-manager. Niu Technologies provided the following description of their company for its IPO: ” ... 
 

Riley Exploration Permian (REPX) to Raise $100 Million in IPO

Riley Exploration Permian (REPX) plans to raise $100 million in an IPO on the week of October 15th, IPO Scoop reports. The company will issue 6,700,000 shares at a price of $14.00-$16.00 per share. In the last twelve months, Riley Exploration Permian generated $57.7 million in revenue and had a net loss of $17.4 million. Riley Exploration Permian has a market cap of $354 million. SunTrust Robinson Humphrey, Seaport Global Securities and Capital One Securities served as the underwriters for the IPO and Imperial Capital and Roth Capital Partners were... 
 

Equillium (EQ) Plans to Raise $70 Million in October 12th IPO

Equillium (EQ) is planning to raise $70 million in an initial public offering on Friday, October 12th, IPO Scoop reports. The company will be issuing 4,700,000 shares at a price of $14.00-$16.00 per share. Jefferies, Leerink Partners and Stifel served as the underwriters for the IPO. Equillium provided the following description of their company for its IPO: ”  We are a biotechnology company leveraging deep understanding of immunobiology to develop products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with... 
 

Anaplan (PLAN) Plans to Raise $217 Million in October 12th IPO

Anaplan (PLAN) expects to raise $217 million in an initial public offering (IPO) on Friday, October 12th, IPO Scoop reports. The company plans to issue 15,500,000 shares at $13.00-$15.00 per share. In the last twelve months, Anaplan generated $199.9 million in revenue and had a net loss of $78.8 million. Anaplan has a market-cap of $1.7 billion. Goldman Sachs, Morgan Stanley and Barclays served as the underwriters for the IPO and KeyBanc Capital Markets, Canaccord Genuity, Evercore ISI, JMP Securities, Needham, Piper Jaffray and SunTrust Robinson... 
 

Allogene Therapeutics Prices IPO at $16.00-$18.00 Per Share (ALLO)

Allogene Therapeutics (ALLO) plans to raise $272 million in an IPO on Thursday, October 11th, IPO Scoop reports. The company will be issuing 16,000,000 shares at a price of $16.00-$18.00 per share. The company has a market-cap of $1.9 billion. Goldman Sachs, J.P. Morgan, Cowen and Jefferies acted as the underwriters for the IPO. Allogene Therapeutics provided the following description of their company for its IPO: ”  We are a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered... 
 

Elastic N.V. (ESTC) Announces October 5th IPO

Elastic N.V. (ESTC) plans to raise $192 million in an initial public offering on Friday, October 5th, IPO Scoop reports. The company plans to issue 7,000,000 shares at a price of $26.00-$29.00 per share. In the last 12 months, Elastic N.V. generated $184.9 million in revenue and had a net loss of $61.3 million. Goldman Sachs, J.P. Morgan, Barclays and RBC Capital Markets acted as the underwriters for the IPO and BofA Merrill Lynch, Citigroup, Jefferies and Canaccord Genuity were co-managers. Elastic N.V. provided the following description of their... 
 

Kodiak Sciences Inc. Plans $126 Million IPO for October 4th (KOD)

Kodiak Sciences Inc. (KOD) plans to raise $126 million in an initial public offering (IPO) on Thursday, October 4th, IPO Scoop reports. The company will be issuing 9,000,000 shares at a price of $13.00-$15.00 per share. The company has a market-cap of $495.1 million. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Barclays and Chardan were co-managers. Kodiak Sciences Inc. provided the following description of their company for its IPO: “We are a clinical stage biopharmaceutical company specializing in novel... 
 

Guardant Health (GH) Announces October 4th IPO

Guardant Health (GH) expects to raise $200 million in an IPO on Thursday, October 4th, IPO Scoop reports. The company plans to issue 12,500,000 shares at $15.00-$17.00 per share. In the last year, Guardant Health generated $67.2 million in revenue and had a net loss of $83.8 million. Guardant Health has a market cap of $1.3 billion. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. Guardant Health provided the following description of their company for its IPO:... 
 

YayYo Plans $5 Million IPO for September 28th (YAYO)

YayYo (YAYO) expects to raise $5 million in an initial public offering on Friday, September 28th, IPO Scoop reports. The company will be issuing 600,000 shares at a price of $7.00-$9.00 per share. In the last 12 months, YayYo generated $240,000 in revenue and had a net loss of $6.5 million. The company has a market-cap of $215.5 million. Benchmark acted as the underwriter for the IPO. YayYo provided the following description of their company for its IPO: ”  The Company is a holding company operating through its wholly-owned subsidiaries,... 
 

Entasis Therapeutics Holdings Plans $75 Million IPO for September 26th (ETTX)

Entasis Therapeutics Holdings (ETTX) plans to raise $75 million in an initial public offering (IPO) on Wednesday, September 26th, IPO Scoop reports. The company will issue 4,400,000 shares at a price of $16.00-$18.00 per share. In the last 12 months, Entasis Therapeutics Holdings generated $5 million in revenue and had a net loss of $33.9 million. Credit Suisse and BMO Capital Markets served as the underwriters for the IPO and SunTrust Robinson Humphrey and Wedbush PacGrow were co-managers. Entasis Therapeutics Holdings provided the following description... 
 

Ra Medical Systems Plans $50 Million IPO for September 27th (RMED)

Ra Medical Systems (RMED) is planning to raise $50 million in an IPO on Thursday, September 27th, IPO Scoop reports. The company will be issuing 3,300,000 shares at $14.00-$16.00 per share. In the last 12 months, Ra Medical Systems generated $5.4 million in revenue and had a net loss of $15.9 million. Ra Medical Systems has a market-cap of $173.1 million. Piper Jaffray and Cantor acted as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers. Ra Medical Systems provided the following description of... 
 

Urovant Sciences Prices IPO at $14.00-$16.00 Per Share (UROV)

Urovant Sciences (UROV) is planning to raise $150 million in an initial public offering (IPO) on Thursday, September 27th, IPO Scoop reports. The company will issue 10,000,000 shares at a price of $14.00-$16.00 per share. The company has a market cap of $450.4 million. J.P. Morgan, Jefferies and Cowen acted as the underwriters for the IPO. Urovant Sciences provided the following description of their company for its IPO: ”  We are a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies... 
 

X Financial Plans $110 Million IPO for September 19th (XYF)

X Financial (XYF) is planning to raise $110 million in an IPO on Wednesday, September 19th, IPO Scoop reports. The company will be issuing 11,000,000 shares at a price of $9.00-$11.00 per share. In the last twelve months, X Financial generated $442.1 million in revenue and $100.9 million in net income. X Financial has a market cap of $1.5 billion. Deutsche Bank Securities and Morgan Stanley acted as the underwriters for the IPO and EBS International, China Merchants Securities (HK) and AMTD Tiger were co-managers. X Financial provided the following... 
 

Arco Platform Ltd. (ARCE) Announces September 26th IPO

Arco Platform Ltd. (ARCE) expects to raise $128 million in an initial public offering (IPO) on Wednesday, September 26th, IPO Scoop reports. The company will issue 11,100,000 shares at $5.50-$17.50 per share. In the last year, Arco Platform Ltd. generated $76.9 million in revenue and $14.9 million in net income. The company has a market-cap of $801.8 million. Goldman Sachs, Morgan Stanley, Itaú BBA and BofA Merrill Lynch served as the underwriters for the IPO and Allen & Company, BTG Pactual and UBS Investment Bank were co-managers. Arco Platform... 
 

Remora Royalties (RRI) Plans to Raise $106 Million in September 21st IPO

Remora Royalties (RRI) plans to raise $106 million in an initial public offering (IPO) on Friday, September 21st, IPO Scoop reports. The company plans to issue 5,300,000 shares at a price of $19.00-$21.00 per share. In the last 12 months, Remora Royalties generated $35.3 million in revenue and had a net loss of $13.8 million. The company has a market cap of $210.4 million. RBC Capital Markets, Wells Fargo Securities, UBS Investment Bank and Stifel served as the underwriters for the IPO and Stephens and Seaport Global Securities were co-managers. Remora... 
 

Bank7 (BSVN) to Raise $64 Million in IPO

Bank7 (BSVN) is planning to raise $64 million in an initial public offering on Thursday, September 20th, IPO Scoop reports. The company will issue 3,300,000 shares at a price of $18.00-$21.00 per share. In the last twelve months, Bank7 generated $43 million in revenue and $15.7 million in net income. Bank7 has a market cap of $197.2 million. Keefe, Bruyette & Woods (A Stifel Company) and Stephens served as the underwriters for the IPO and Sandler O’Neill + Partners was co-manager. Bank7 provided the following description of their company for... 
 

Y-mAbs Therapeutics Prices IPO at $14.00-$16.00 Per Share (YMAB)

Y-mAbs Therapeutics (YMAB) expects to raise $80 million in an initial public offering on Friday, September 21st, IPO Scoop reports. The company will be issuing 5,300,000 shares at $14.00-$16.00 per share. Y-mAbs Therapeutics has a market cap of $489.4 million. BofA Merrill Lynch, Cowen and Canaccord Genuity served as the underwriters for the IPO and BTIG was co-manager. Y-mAbs Therapeutics provided the following description of their company for its IPO: ”  We are a late-stage clinical biopharmaceutical company focused on the development... 
 

Eventbrite Prices IPO at $19.00-$21.00 Per Share (EB)

Eventbrite (EB) is planning to raise $200 million in an IPO on Friday, September 21st, IPO Scoop reports. The company plans to issue 10,000,000 shares at a price of $19.00-$21.00 per share. In the last 12 months, Eventbrite generated $255.5 million in revenue and had a net loss of $45.8 million. Eventbrite has a market-cap of $1.6 billion. Goldman Sachs, J.P. Morgan, Allen & Company and RBC Capital Markets acted as the underwriters for the IPO and SunTrust Robinson Humphrey and Stifel were co-managers. Eventbrite provided the following description... 
 

111, Inc. Plans $140 Million IPO for September 12th (YI)

111, Inc. (YI) expects to raise $140 million in an initial public offering on Wednesday, September 12th, IPO Scoop reports. The company plans to issue 9,300,000 shares at a price of $14.00-$16.00 per share. In the last twelve months, 111, Inc. generated $184 million in revenue and had a net loss of $37.3 million. The company has a market cap of $702.9 million. J.P. Morgan, Citigroup and CICC served as the underwriters for the IPO. 111, Inc. provided the following description of their company for its IPO: ”  Our mission is to build the... 
 
© 2006-2018 Ticker Report. Google+.